Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studies.
Journal: RMD open
Published: February 16, 2018
Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis.
Journal: Journal of pain research
Published: February 02, 2018
Effect of psoriatic arthritis on ixekizumab clinical outcomes in moderate-to-severe psoriasis patients: A post hoc analysis.
Journal: Journal of the American Academy of Dermatology
Published: July 17, 2017
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3).
Journal: Annals of the rheumatic diseases
Published: May 21, 2015
Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapy.
Journal: Rheumatology (Oxford, England)
Published: April 30, 2014
Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial.
Journal: Rheumatology (Oxford, England)
Published: February 19, 2013
Intra-articular hylastan versus steroid for knee osteoarthritis.
Journal: Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
Published: June 15, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026